SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-134451
Filing Date
2012-03-27
Accepted
2012-03-27 16:32:58
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d280818d10k.htm 10-K 1179187
2 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d280818dex231.htm EX-23.1 2952
3 CERTIFICATION OF CHIEF EXECUTIVE d280818dex311.htm EX-31.1 9421
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER d280818dex312.htm EX-31.2 9423
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d280818dex321.htm EX-32.1 6485
  Complete submission text file 0001193125-12-134451.txt   3852110

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abio-20111231.xml EX-101.INS 416699
7 XBRL TAXONOMY EXTENSION SCHEMA abio-20111231.xsd EX-101.SCH 20559
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20111231_cal.xml EX-101.CAL 38589
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20111231_def.xml EX-101.DEF 67056
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20111231_lab.xml EX-101.LAB 183645
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20111231_pre.xml EX-101.PRE 132383
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 12717504
SIC: 2835 In Vitro & In Vivo Diagnostic Substances